General decapping activators target different subsets of inefficiently translated mRNAs.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30520724.
- Also identified by DOI 10.7554/eLife.34409 and PMC identifier 6300357.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The Dcp1-Dcp2 decapping enzyme and the decapping activators Pat1, Dhh1, and Lsm1 regulate mRNA decapping, but their mechanistic integration is unknown. We analyzed the gene expression consequences of deleting <i>PAT1, LSM1,</i> or <i>DHH1,</i> or the <i>DCP2</i> C-terminal domain, and found that: i) the Dcp2 C-terminal domain is an effector of both negative and positive regulation; ii) rather than being global activators of decapping, Pat1, Lsm1, and Dhh1 directly target specific subsets of yeast mRNAs and loss of the functions of each of these factors has substantial indirect consequences for genome-wide mRNA expression; and iii) transcripts targeted by Pat1, Lsm1, and Dhh1 exhibit only partial overlap, are generally translated inefficiently, and, as expected, are targeted to decapping-dependent decay. Our results define the roles of Pat1, Lsm1, and Dhh1 in decapping of general mRNAs and suggest that these factors may monitor mRNA translation and target unique features of individual mRNAs.
Medical subject headings
- DEAD-box RNA Helicases
- Protein Biosynthesis
- RNA Cap-Binding Proteins
- RNA-Binding Proteins
- Saccharomyces cerevisiae Proteins